• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫癌肉瘤。

Uterine carcinosarcoma.

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.

出版信息

Curr Opin Oncol. 2011 Sep;23(5):531-6. doi: 10.1097/CCO.0b013e328349a45b.

DOI:10.1097/CCO.0b013e328349a45b
PMID:21743326
Abstract

PURPOSE OF REVIEW

To summarize the clinical characteristics, epidemiology, and treatment of uterine carcinosarcoma.

RECENT FINDINGS

Recent studies have suggested that uterine carcinosarcomas are aggressive neoplasms that carry a poor prognosis even when diagnosed at an early stage. Treatment is typically surgical. The ideal adjuvant treatment remains unknown. A number of recent studies have examined the influence of radiation, chemotherapy, and combinations of chemotherapy and radiation for uterine carcinosarcoma.

SUMMARY

Carcinosarcoma is an aggressive neoplasm. A number of studies are underway to determine the optimal adjuvant therapy for these tumors.

摘要

目的综述

总结子宫癌肉瘤的临床特征、流行病学和治疗。

最新发现

最近的研究表明,子宫癌肉瘤是一种侵袭性肿瘤,即使在早期诊断,预后也很差。治疗通常是手术。理想的辅助治疗仍然未知。一些最近的研究检查了放射治疗、化疗以及化疗和放疗联合治疗子宫癌肉瘤的影响。

总结

癌肉瘤是一种侵袭性肿瘤。目前正在进行多项研究以确定这些肿瘤的最佳辅助治疗。

相似文献

1
Uterine carcinosarcoma.子宫癌肉瘤。
Curr Opin Oncol. 2011 Sep;23(5):531-6. doi: 10.1097/CCO.0b013e328349a45b.
2
Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.伴有肉瘤过度生长的子宫腺肉瘤与子宫癌肉瘤:治疗与生存情况比较
Gynecol Oncol. 2001 Oct;83(1):89-94. doi: 10.1006/gyno.2001.6334.
3
An update on the management of uterine carcinosarcoma.子宫癌肉瘤治疗的最新进展。
Obstet Gynecol Surv. 2011 Nov;66(11):710-6. doi: 10.1097/OGX.0b013e31823e0c44.
4
Uterine Carcinosarcomas - Diagnosis and Management.子宫癌肉瘤-诊断与治疗。
Oncol Res Treat. 2018;41(11):675-679. doi: 10.1159/000494335. Epub 2018 Oct 13.
5
[Carcinosarcomas in female genital tracts: general review].[女性生殖道癌肉瘤:综述]
Bull Cancer. 2014 Jul-Aug;101(7-8):760-4. doi: 10.1684/bdc.2014.1937.
6
[Carcinosarcoma of the uterus. Clinical case and review of the literature].[子宫癌肉瘤。临床病例及文献综述]
Rev Fr Gynecol Obstet. 1992 Jan;87(1):39-41.
7
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study.子宫癌肉瘤:一项临床病理多中心CTF研究
Gynecol Oncol. 1997 Oct;67(1):70-5. doi: 10.1006/gyno.1997.4827.
8
Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy.保守治疗的手术I期子宫癌肉瘤的失败模式:对辅助治疗的启示
Int J Gynecol Cancer. 2009 Jul;19(5):888-91. doi: 10.1111/IGC.0b013e3181a831fb.
9
COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?子宫癌肉瘤中COX-2、c-KIT和HER-2/neu的表达:预后因素还是靶向治疗的潜在标志物?
Gynecol Oncol. 2005 Jan;96(1):159-67. doi: 10.1016/j.ygyno.2004.09.050.
10
Review literature on uterine carcinosarcoma.回顾关于子宫癌肉瘤的文献。
J Cancer Res Ther. 2014 Jul-Sep;10(3):461-8. doi: 10.4103/0973-1482.138197.

引用本文的文献

1
Carcinosarcoma of Uterus and Ovary-Clinical, Morphological, and Immunohistochemical Study of Case Series.子宫和卵巢癌肉瘤——病例系列的临床、形态学及免疫组织化学研究
J Pharm Bioallied Sci. 2025 Jun;17(Suppl 2):S2021-S2024. doi: 10.4103/jpbs.jpbs_1658_24. Epub 2025 Jun 18.
2
A case report of comprehensive treatment for primary intraspinal carcinosarcoma.原发性椎管内癌肉瘤综合治疗1例报告
Front Oncol. 2025 Jan 7;14:1479193. doi: 10.3389/fonc.2024.1479193. eCollection 2024.
3
Uterine Carcinosarcoma (UCS): A Literature Review and Survival Analysis from a Retrospective Cohort Study.
子宫癌肉瘤(UCS):一项回顾性队列研究的文献综述与生存分析
Cancers (Basel). 2024 Nov 21;16(23):3905. doi: 10.3390/cancers16233905.
4
Strategic multidisciplinary management of pelvic carcinosarcoma: Emphasizing advanced diagnostic imaging and staged surgical interventions.盆腔癌肉瘤的多学科综合治疗策略:强调先进的诊断性影像学检查和分期手术干预。
Radiol Case Rep. 2024 Aug 6;19(10):4583-4598. doi: 10.1016/j.radcr.2024.07.005. eCollection 2024 Oct.
5
Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma.鉴别子宫癌肉瘤与子宫内膜样腺癌的临床及多参数MRI特征
BMC Med Imaging. 2024 Feb 19;24(1):48. doi: 10.1186/s12880-024-01225-4.
6
Racial and Ethnic Disparities in Gynecologic Carcinosarcoma: A Single-Institution Experience.妇科癌肉瘤的种族和民族差异:单机构经验
Cancers (Basel). 2023 Sep 23;15(19):4690. doi: 10.3390/cancers15194690.
7
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/neu expression.曲妥珠单抗 deruxtecan(DS-8201a),一种靶向 HER2 的抗体药物偶联物,含有拓扑异构酶 I 抑制剂有效载荷,在表达 HER2/neu 的子宫和卵巢癌肉瘤中显示出抗肿瘤活性。
Gynecol Oncol. 2023 Mar;170:38-45. doi: 10.1016/j.ygyno.2022.12.018. Epub 2023 Jan 5.
8
cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma.cERBB-2/Her-2 过表达与子宫癌肉瘤的预后意义。
Turk Patoloji Derg. 2023;39(1):55-63. doi: 10.5146/tjpath.2022.01588.
9
Primary Cervical Carcinosarcoma: Report of a Rare Case.原发性宫颈癌肉瘤:1例罕见病例报告。
Surg J (N Y). 2022 Aug 2;8(3):e174-e178. doi: 10.1055/s-0042-1744152. eCollection 2022 Jul.
10
Advances in the Preoperative Identification of Uterine Sarcoma.子宫肉瘤术前诊断的进展
Cancers (Basel). 2022 Jul 20;14(14):3517. doi: 10.3390/cancers14143517.